SOME OF OUR WOMEN'S HEALTH + HEALTH TECH COMPANIES
LED BY VISIONARY, VALUE-CREATING INVESTORS WHO HAVE VETTED 5,000+ COMPANIES AND LED $9B+ IN TRANSACTIONS.
OUR FOCUS
Supporting founders using innovative technology and science across the following markets.
WE RECOGNIZE
That women were excluded from clinical research for too long, and it is up to us to make up for that deadly data gap. It is time to
accelerate progress in women's health, transforming technology and scientific advancements into successful companies that
improve women's lives.
WOMEN’S HEALTH
We know that women’s health is more than fertility and menopause. It includes the entire woman, for her entire life. Our focus on women’s health includes areas in which women are differently and disproportionately impacted. Some fields of interest include autoimmune, GI, brain health, microbiome, endocrine, and heart health, but there are many more. Our team also has expertise in medical aesthetics and dermatology.
WELLNESS
Wellness includes the many factors that directly and indirectly contribute to health. Nutrition, exercise, lifestyle, environment, preventative care, skin health and relationships significantly impact overall outcomes.
HEALTH TECH
Advancements in health tech provide a meaningful and measurable way to improve lives today. And as women make the majority of health decisions for the family, they are disproportionately impacted by the burden of a dysfunctional system. From B2B SaaS platforms to AI data plays to digital therapeutics, we invest in software and systems that increase access, improve efficiency, and positively impact the global health ecosystem.
EVERY HUMAN BEING ON THE PLANET EXISTS BECAUSE OF
WOMEN’S HEALTH. IT’S TIME WE INVEST ACCORDINGLY.
Jessica Federer | Managing Partner
ABOUT US
Founded in 2017 by Laurel Touby, a successful former founder and investor, the Supernode Ventures inaugural fund
focused on early-stage, sector-agnostic tech companies. Given the impact and growth of the health tech space, the first
fund included a dozen companies in that category, including both B2B and B2C companies.
Inspired by the opportunity in this sector, Laurel teamed up with Jessica Federer and Mike Jafar to focus on companies
delivering innovations that improve women’s health, medical aesthetics, and the broader health technology
ecosystem. Together, this multi-disciplinary trifecta brings their experience across health, technology and media to
advance businesses that improve women’s health, as well as the broader health tech ecosystem.
LAUREL TOUBY
Managing Partner
Laurel Touby is a former business journalist, internet pioneer and investor.
After a successful career as a business journalist, Laurel founded mediabistro.com in 1996, a company that became the most influential media community in the US. After exiting her company and providing a 14x return to investors, Touby then launched Supernode I, a sector-agnostic fund with 10 health tech companies.
MICHEAL JAFAR
Founding Partner
Michael Mazen Jafar is a former CEO, healthcare leader and investor.
Michael brings his experience as a CEO, CMO, and health executive to Supernode. Between Allergan and Desktop Health, Michael assessed 500+ companies and deployed ~$9 billion in M&A activity. He brings tremendous value to founders and management teams gearing to scale.
JESSICA FEDERER
Managing Partner
Jessica Federer is a former big pharma CDO, health tech leader and investor.
Jessica was one of the first Chief Digital Officers in the Pharma industry, building on a data-focused career in regulatory market access and product launches. She transitioned to venture in 2017 at Boston Millennia Partners, then to Supernode for Fund II to focus on early stage health tech companies and women’s health.